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Replication from oriP of Epstein-Barr Virus
Requires Human ORC
and Is Inhibited by Geminin
tion to this problem is to develop either conditional or
hypomorphic mutations in ORC genes in mammalian
cells. We have reported that hypomorphic mutations in
Drosophila ORC3 produced enough Orc3 protein to
allow viability but exhibited a specific proliferation de-
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fect in midbrain neuroblasts during development (PintoBrigham and Women’s Hospital and Harvard
et al., 1999). Another recent development has been theMedical School
use of homologous recombination to alter chromosomalBoston, Massachusetts 02115
genes in mammalian somatic cells in culture (Chan et2 Department of Biochemistry and Molecular
al., 1999; Lengauer et al., 1997; Waldman et al., 1995).Biology
In this paper, we combine these ideas to engineer aWright State University
hypomorphic mutation in the human ORC2 gene in aDayton, Ohio 45435
cancer cell line.3 Department of Cancer Genetics
The function of ORC is best understood in yeast andRoswell Park Cancer Institute
Xenopus egg extracts and is connected to “replicationBuffalo, New York 14263
licensing,” the mechanism by which eukaryotic DNA
replication is limited to once per cell cycle (Blow and
Laskey, 1986; Dutta and Bell, 1997; Laskey and Madine,Summary
1996; Stillman, 1996). ORC is bound to origins of DNA
replication throughout the cell cycle. In G1 phase, ORCA hypomorphic mutation made in the ORC2 gene of a
recruits CDC6 and Cdt1, which in turn recruit the MCMhuman cancer cell line through homologous recombi-
complex to form a prereplicative complex (pre-RC)nation decreased Orc2 protein levels by 90%. The G1
(Cocker et al., 1996; Diffley et al., 1995). At the G1-Sphase of the cell cycle was prolonged, but there was no
transition, the action of cyclin-dependent kinases pro-effect on the utilization of either the c-Myc or -globin
motes the loading of CDC45, RPA, and DNA polymer-cellular origins of replication. Cells carrying this muta-
ases at the replication origin and DNA synthesis is initi-tion failed to support the replication of a plasmid bear-
ated. The increased activity of cyclin-dependent kinasesing the oriP replicator of Epstein Barr virus (EBV), and
prevents a second round of replication initiation at ori-this defect was rescued by reintroduction of Orc2.
gins that have already initiated one round of DNA synthe-Orc2 specifically associates with oriP in cells, most
sis. In addition, a protein called geminin appears in thelikely through its interaction with EBNA1. Geminin, an
cell to inhibit Cdt1 to provide a second mechanism byinhibitor of the mammalian replication initiation com-
which rereplication is prevented (McGarry and Kirschner,plex, inhibits replication from oriP. Therefore, ORC and
1998; Tada et al., 2001; Wohlschlegel et al., 2000). Onlythe human replication initiation apparatus is required
after cells have passed through mitosis and entered thefor replication from a viral origin of replication.
next G1 are the cyclins and geminin degraded to allow
the reassembly of pre-RCs for the next round of DNAIntroduction
synthesis.
Epstein-Barr virus (EBV) is a 165 kb double-strandedOrigin-recognition Complex (ORC) was identified in S.
DNA virus of the herpesvirus family that replicates ascerevisiae as a complex of proteins essential for the
an episome in latently infected cells. B cells or epithelial
initiation of DNA replication (Bell and Stillman, 1992).
cells are latently infected by EBV in 90% of humans and
ORC has subsequently been identified in other species
can cause carcinomas and lymphoproliferative disease
and shown to be functionally important for DNA replica- in immunosuppressed patients. To prevent this prob-
tion during development in Drosophila (Austin et al., lem, it is essential that we learn how these viral episomes
1999; Chesnokov et al., 1999; Gossen et al., 1995; Landis replicate in human cells and devise strategies to inter-
et al., 1997) and in Xenopus egg extracts (Carpenter et fere with the process. A 1.7 kb region of the EBV chromo-
al., 1996). Individual ORC subunits have been identified some, oriP, supports the replication and maintenance
in humans and other mammals (Dhar and Dutta, 2000; of recombinant plasmids in human cells in the presence
Gavin et al., 1995; Pinto et al., 1999; Quintana et al., of a single EBV-encoded protein, EBNA-1 (Yates et al.,
1997; Thome et al., 2000; Tugal et al., 1998), but their 1985). Replication initiates at or near a 120 bp compo-
role in mammalian cells is still unclear because of the nent of oriP called DS (dyad symmetry), which binds
absence of appropriate genetic or biochemical systems EBNA-1 and is the functional replicator of oriP (Gahn
for such study. and Schildkraut, 1989; Harrison et al., 1994; Yates et al.,
Because ORC is expected to be essential for viability, 2000). Since EBNA-1 appears to lack enzymatic activity
a standard gene knockout approach in mouse is unlikely (Frappier and O’Donnell, 1991; Middleton and Sugden,
to give much information beyond the fact that the genes 1992), initiation of DNA replication at oriP must rely on
are essential for normal development. A potential solu- cellular proteins. Plasmids bearing oriP are replicated
no more than once per cell cycle (Yates and Guan, 1991),
suggesting that the plasmids are controlled by replica-4 Correspondence: adutta@rics.bwh.harvard.edu
5 These authors contributed equally to this work. tion licensing.
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Figure 1. Targeted Disruption of the Human
ORC2 gene
(A) WT ORC2 locus with the targeting vector
and the resulting mutated locus. Solid boxes
represent the first 4 exons. Probes used for
Southern blot analysis are indicated. Recom-
bination between the vector and endogenous
locus deletes 72 bp of exon 3 containing the
ATG.
(B) Southern blot of EcoRI- or SphI-digested
genomic DNA from targeted and wild-type
HCT116 cells hybridized with the probes
shown in (A). The asterisks indicate DNA frag-
ments specific to the mutated () allele: a
5 kb EcoRI fragment recognized by the neo
probe or the 3 probe and a 4 kb SphI frag-
ment recognized by the 3 probe.
(C) Cre-mediated recombination of the /
cells obtained in (B) produces a / cell
where the excision of the Neo cassette leaves
a loxP site in exon 3 (). The second round
of targeting can either create a / cell or a
/ cell. PCR with indicated primers “a” and
“c” produce the diagnostic PCR products
shown to the right of each allele. EcoRI diges-
tion of the PCR products yields the fragments
in parentheses.
(D) Genomic PCR of the cell clones to identify
products of the second round of homologous
recombination. Genomic DNA prepared from
parental / clone and from / or /
product clones were subjected to PCR with
primer pairs “a” and “c” shown in (C). Gel
electrophoresis and ethidium bromide stain
to visualize the products of the PCR reaction
(top) or the fragments produced by EcoRI di-
gestion of the PCR products (bottom).
In this paper, we show that the cells with a hypomor- combination of the loxP sites flanking the NEO gene
excised the NEO cassette, made the cells susceptiblephic mutation in human ORC2 survive with only a slight
prolongation of the G1 phase of the cell cycle. They do to G418, and left a loxP site in place of most of exon3
in the allele called -ORC2. (Figure 1C; /).not permit EBNA1-dependent replication of episomes
from oriP, but this replication is restored upon expres- The second allele of ORC2 was targeted with the same
vector followed by G418 selection. Retargeting of thesion of wild-type Orc2 in these cells. Orc2 in cells is
specifically associated with oriP and coimmunoprecipi- loxP marked allele () recreates the  allele in cells
called / (Figure 1C). PCR screening of genomic DNAtates with EBNA1. Finally, cotransfection with geminin
suppresses replication from oriP and this is rescued with the indicated primers produces a 352 bp product
from the  allele that is cut by EcoRI into fragments ofby overexpression of Cdt1. Taken together, this data
suggests that ORC and other human initiation factors 204 and 148 bp. Targeting of the wild-type ORC2 allele,
on the other hand, creates the desired cell-line (/)are required for replication from oriP. This is demonstra-
tion of the use of eukaryotic replication proteins in the (Figure 1C). PCR screening produces a 313 bp product
from the  allele that is cut by EcoRI into fragments ofinitiation of DNA replication from a viral origin of replica-
tion. The result concurrently identifies a novel means by 204 and 109 bp. PCR analysis identified 8.8% of the
G418-resistant clones as / mutants at the ORC2 lo-which to inhibit latent infection of Epstein Barr virus for
therapeutic purposes. cus (Figure 1D, /).
The -ORC2 Allele Produces a Low LevelResults
of an N Terminally Truncated Orc2 Protein
In a conventional gene deletion experiment, transcrip-Mutation of ORC2
Homologous recombination was used to replace the tion and polyadenylation of the drug resistance cas-
settes inserted in the two alleles of the target gene pre-third exon of ORC2 (encoding the initiator ATG) in
HCT116 colon carcinoma cells with a Neomycin phos- vents residual expression of the latter. In the strategy
employed here, however, only a loxP site is left in thephotransferase (NEO) gene (Figure 1A). ORC2 /
clones were identified in 2%–3% of G418-resistant colo- middle of exon 3 in the  allele. Although the initiator
ATG is removed, low levels of a variant ORC2 mRNAnies by Southern blotting (Figure 1B). Cre-mediated re-
ORC and Latent EBV Replication
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Figure 2. Biochemical Characterization of
ORC in the / Cells
(A) Western blot analysis of total cell lysates
using -Orc2, -Orc3, and -Orc4 antibodies.
Five micrograms of lysates of WT (/) or
/ cells loaded per lane.
(B) Indicated amounts of cell lysates were
loaded to quantitate the low level of the 68
kDa Orc2 protein in the lysates of / cells.
(C) Detection of various replication proteins
in the chromatin fraction of WT and / cells.
Two, four, and eight micrograms of protein
from the chromatin fraction immunoblotted
with antibodies to indicated proteins.
(D) Immunoprecipitation of 100g of chroma-
tin proteins from WT and / cells with
-Orc2 antibody followed by immunoblotting
with antibodies to Orc2 and Orc3.
(E) Immunoblotting of 10 g of cell lysates
from 293 (human embryonic kidney), HeLa
(cervical carcinoma), U2OS (osteosarcoma),
and HCT116 (colon carcinoma) cell lines with
-Orc2 antibody. Ponceau S stain is shown
as a loading control.
produced by read-through transcription or alternative antibody and coimmunoprecipitated with Orc3, sup-
porting the hypothesis that it is derived from the-ORC2splicing could express an N terminally deleted Orc2 pro-
tein from methionine-74 encoded by exon 4. Although locus (Figure 2D).
an -Orc2 antibody did not recognize the full-length 72
kDa Orc2 protein in the / cells (Figure 2A), an Orc2- The Hypomorphic Mutation in ORC2 Prolongs
related polypeptide of 68 kDa was detected when 10 G1 Phase of the Cell Cycle
times more cell lysate was analyzed (Figure 2B). Be- The proliferation rate of the ORC2 / cells was de-
cause the 68 kDa protein (Orc2) was seen only in cells creased by 30% (doubling time 43 hr versus 33.5 hr
with the ORC2 allele, the polypeptide was most likely in ORC2 / or / cells) (Figure 3A). There was no
the product of the loxP-marked -ORC2 locus. increase in apoptosis or senescence in the / cells
(data not shown). FACS to measure the DNA content
of asynchronously growing cells indicated a moderateEffect of the Hypomorphic Mutation in ORC2
on the Other ORC Subunits increase in the G1 phase population in the / cells
(Table 1), suggesting a prolongation of G1. ConsistentThe / cells express Orc2 protein at 10% of the level
of full-length Orc2 seen in wild-type (WT) cells. The level with this finding, the percentage of cells entering S
phase in / cells in the 24 hr following release from aof Orc4 was unchanged in the / cells, while Orc3
levels were markedly decreased (Figure 2A). ORC3 mimosine induced G1-S block (Gilbert et al., 1995) is
about half that in the WT cells (Figure 3B). [3H]thymidinemRNA is expressed at normal levels in the / cells
(data not shown), suggesting that the decrease of Orc3 incorporation over 3 days in two different clones of /
cells was also 30%–40% that of WT cells (Figure 3C).protein is due to posttranscriptional mechanisms. Previ-
ous studies have shown that Orc3 and Orc2 are tightly [3H]thymidine incorporation in cultures released from a
mimosine induced G1-S block showed that the heightbound to each other in cells (Thome et al., 2000). There-
fore, it is possible that the decrease in Orc2 protein in of the incorporation curve is decreased to 60%–70%
without any change in the width of the curve (Figurethe / cells results in free Orc3 that is unstable and
subsequently degraded. 3D). This suggests that fewer cells enter S phase when
Orc2 activity is compromised, but DNA replication isImmunoblotting different concentrations of protein
from the chromatin fraction of cells indicated that the normal once the cells enter S phase so that the duration
of S phase is unchanged. Based on these four differentamounts of chromatin-associated Orc2, Orc3, and
Orc4 were decreased to less than 25% in the / cells assays for cellular proliferation, we find that / cells
proliferate at approximately 50% of the rate of WT cells.(Figure 2C and data not shown). The DNA replication
factor RPA70 is present on the chromatin at normal The slight differences between the results of these
assays likely reflect the fact that different parameterslevels in the / cells, providing a positive control for
chromatin recovery. We also show that the 68 kDa pro- are being measured. For example, the MTT assay in
Figure 3A measures the metabolic activity of cells, whiletein in / cells was immunoprecipitated by anti-Orc2
Cell
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Figure 3. ORC2 / Cells Are Compromised
in Cell Proliferation
(A) Cell proliferation of the indicated cell lines
measured by MTT assay. Doubling times
were determined by fitting the data to an ex-
ponential curve.
(B) FACS analysis for DNA content of /
(WT) and / HCT116 cells. Cells synchro-
nized at the G1-S boundary by mimosine (left)
and 24 hr following release from the mimosine
block (right).
(C) [3H]thymidine incorporation of / and
two separate clones of / cells. Compari-
son of thymidine incorporation of asynchro-
nous cells growing over 3 days in culture, with
the incorporation in / cells held at 100%.
Mean and standard deviation of 4 measure-
ments.
(D) Incorporation of thymidine during 1 hr
pulses at indicated time points following re-
lease from mimosine block. The thymidine
incorporation at each time point is normalized
to the incorporation of that cell line in the 0
hr time point.
in Figure 3C, [3H]thymidine incorporation specifically Abundance of Orc2 in Several Cell Lines
To ensure that the HCT116 cells did not contain atypi-measures DNA replication.
cally high levels of Orc2, we compared levels of Orc2
in four commonly used cancer cell lines (Figure 2E). Orc2Replication Initiation Activity Is Unchanged at Two
Chromosomal Origins of Replication levels in HCT116 colon cancer cells were about half
that in 293 or HeLa cells. Therefore, the excess of Orc2The lack of a significant prolongation of S phase sug-
gests that in the / cells that do enter S phase, either relative to what is essential for chromosomal replication
is a feature of several cancer cells.the normal complement of origins is active, or the num-
ber of origins firing per chromosome can be significantly
decreased without affecting the duration of S phase. To The Hypomorphic Mutation in ORC2 Impairs
examine the initiation activity at chromosomal sites, the Replication from the oriP of EBV
abundance of short nascent DNA strands was quanti- To test whether cellular Orc2 is required to support EBV
tated by PCR at two loci containing known origins of replication, a plasmid carrying oriP, EBNA-1 and a hy-
DNA replication, c-myc and -globin (Figure 4). In both gromycin resistance gene (p220.2) was transfected into
of these regions, the abundance and size distribution WT and / cells (Figure 5A). Replication of p220.2
of DNA nascent strands suggests that there are multiple, allowed hygromycin resistant colonies to emerge in the
nonrandom sites of replication initiation (Kamath and WT cells but not in the/cells. DpnI-resistant plasmids
Leffak, 2001; Malott and Leffak, 1999; Tao et al., 2000). were recovered from these colonies indicating that the
The pattern of nascent strand abundance at these spe- transfected plasmids had replicated in the WT cells (Fig-
cific initiation sites was unchanged between / and ure 5B, lane 1). pBabe-Puro, a plasmid that does not
/ cells, suggesting that at least for these two origins, have oriP or EBNA-1 and is integrated in the host cell
replication initiated normally in the / cells that do chromosome was used as a control and produced the
enter S phase. same size and number of puromycin-resistant colonies
in WT and / cells (Figure 5A). Therefore, the / and
/ cells are not inherently different in their transfection
Table 1. Percentage of Cells in Different Phases of the Cell Cycle efficiency or in their expression of drug resistance mark-
(Mean and Standard Deviation of 3 Determinations for WT Cells and
ers. The observation that the size and number of the6 Determinations for /cells)
puromycin-resistant colonies is similar in WT and /
HCT116 cells G1 S G2/M cells also indicates that the inability of the plasmid
WT 24.4 (1.2) 51.7 (1.9) 23.9 (1.1) p220.2 to replicate cannot be due to the difference in
/ 33.8 (3.2) 42.2 (1.6) 24.0 (2.3)
proliferation rates between the two cell lines.
ORC and Latent EBV Replication
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Figure 4. Relative Abundance of Nascent
DNA Strands in the c-Myc and -Globin Loci:
Comparison of WT (/) HCT116 Cells and
/ HCT116 Cells
The abundance of 1–2 kb nascent DNAs at
four sequence-tagged sites in the c-Myc lo-
cus and at five sequence-tagged sites in the
-globin locus in wild-type (/) and ORC2
mutant (/) cells. Maps show the c-Myc P1
promoter (arrow) and exons (boxes), and the
cluster of globin genes (boxes) and locations
of the primers used. Means and standard de-
viations of 6–12 PCRs on each of three or
four independent nascent DNA preparations
from each cell type. Values are normalized to
the abundance at Myc3.
To confirm that the / cells did not support replica- associates physically with oriP, chromatin immunopre-
tion from oriP, a transient replication assay was per- cipitation (ChIP) assays were performed on chromatin
formed (Figure 5B). p367 (with wild-type oriP and ex- prepared from human 293 cells that carried multiple
pressing EBNA-1) (Yates et al., 2000) was transfected copies of a 12.6 kb oriP-dependent plasmid (p818, Fig-
into WT and / cells. Ninety-six hours after transfec- ure 6A). DNA was recovered from chromatin precipitated
tion, DpnI-resistant (replicated) p367 plasmids were de- by antibodies specific to EBNA-1 or Orc2, or by nonim-
tected by Southern blotting (Figure 5B, lanes 6 and 7). mune serum, and analyzed by PCR for four regions of the
Quantitation of the DpnI-resistant DNA in the blots (Fig- plasmid simultaneously. The four regions of the plasmid
ure 5C) showed that replication was decreased to less were amplified by PCR using DNA from de-cross-linked
than 10% in the / cells compared to WT cells, sug- chromatin (lanes 7–9). The results indicate that chroma-
gesting that ORC was necessary for efficient replication tin containing the DS region of the plasmid was specifi-
from oriP. As in the stable replication assay, the fact cally precipitated by antibodies against Orc2 (lanes 1–2),
that the replication of the oriP-containing plasmids was as well as EBNA-1 (lanes 5–6), but not by nonimmune
reduced by 90% while the proliferation rate between serum (lanes 3–4). The nonimmune sera used for this
/ and WT cells differs only by 50% also strongly experiment included antibodies against a splicing fac-
suggests that the inability of the oriP plasmid to replicate tor, Upf1, and against an EBV-encoded protein, LMP-2.
cannot be attributed to the slower growth rate of the The data indicate that Orc2, and by extension ORC, is
/ cells. physically linked to DS, the replicator of oriP.
If the defect in OriP-based plasmid replication in /
cells is due to the mutation in ORC2, expression of wild-
Orc2 Interacts with EBNA1type Orc2 protein should rescue the replication defect.
If ORC and proteins downstream from ORC are requiredInfection of HCT116 / cells with an adenovirus vector
for replication from oriP, we hypothesized that the ORCthat expresses Orc2 resulted in the reappearance of
is recruited to the latter through the viral protein EBNA1.wild-type 72 kDa Orc2 protein in the cell extracts (Figure
Immunoprecipitation of lysates of DG75 cells carrying5D). Following infection with Adeno-Orc2 or with nega-
tive control Adeno-GFP (expressing green fluorescent p818 with anti-Orc2 antibody coimmunoprecipitated a
protein), the HCT116 / cells were transfected with small but reproducible amount of EBNA1 (Figure 6B).
p367 (Figure 5E). The increase in DpnI-resistant plasmid Therefore, ORC is most likely recruited to oriP via pro-
DNA in lane 4 (compared to lane 3) and the quantitation tein-protein interactions with EBNA1.
of the result (Figure 5F) indicates that the transient ex-
pression of wild-type Orc2 in / cells partially restored
Geminin Inhibits Replication from oriP of EBVreplication from OriP.
If ORC is required for replication from oriP, we reasonedThe failure of / cells to support replication of an
that other components of the replication initiation com-OriP-based plasmid could be because of the low level
plex might also be required. Geminin, a regulator ofof Orc2 or because Orc2 is missing a critical region
the cell cycle, interacts with one of these downstreamessential for EBV replication. Cotransfection of p367
components, Cdt1, to prevent the loading of MCM pro-with a plasmid overexpressing FLAG-tagged Orc2 res-
teins (Wohlschlegel et al., 2000). Geminin is degradedcued replication from OriP effectively (data not shown),
by the anaphase-promoting complex and can be stabi-suggesting that the defect in / cells was due to the
lized by mutation of a specific destruction box (gemi-low level of Orc2 and not a qualitative defect in the
ninDB) (McGarry and Kirschner, 1998). p367 (a plasmidOrc2 protein.
containing oriP and EBNA1) was cotransfected into
HCT116 cells with plasmid pEBG expressing glutathioneOrc2 Is Specifically Associated with the oriP
S transferase (GST) as a control or with plasmids ex-of EBV Chromosomes in Cells
pressing GST-geminin or GST-gemininDB (Figure 7A).The above results suggest that ORC has a positive role
in replication from oriP. To investigate whether ORC Judging from the amount of DpnI resistant replicated
Cell
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Figure 5. Orc2 / Cells Are Defective in
DNA Replication from oriP of EBV and This
Defect Is Rescued by Expression of Wild-
Type Orc2
(A) Establishment of drug-resistant colonies
of WT and/ cells after transfection of plas-
mid p220.2 carrying EBV oriP, EBNA-1 and
the hygromycin resistance marker or of
pBabe-Puro, a plasmid containing a puromy-
cin resistance gene as a control. Following
selection in hygromycin (top) or puromycin
(bottom), colonies were visualized by staining
with crystal violet.
(B) Southern Blot to detect DpnI-resistant
plasmids that have replicated in mammalian
cells. In indicated lanes, DpnI was used to
digest unreplicated DNA retaining the dam
methylation acquired in E. coli. Plasmid DNA
in all lanes was linearized with BamHI and
detected by probing with the entire plasmid.
The plasmids were either obtained after
transfection of HCT116 cells (/ or /) or
from E. coli (Bact). Lane 1: Stable replication
of p220.2 in hygromycin resistant colonies
derived from WT HCT116 cells 10 days after
transfection. Lanes 6–7: Transient replication
of p367 96 hr following transfection of indi-
cated cell lines. Lanes 2–5: Plasmid obtained
directly from bacteria, mixed with cellular ge-
nomic DNA from mock-transfected cells and
digested with indicated enzymes to provide
size markers for DpnI-resistant plasmid
(lanes 3 and 4) and control for complete DpnI
digestion (lanes 2 and 5).
(C) Quantitation of replication in / cells
(from Figure 5B). The relative intensities com-
pare the normalized intensities of the DpnI
resistant DNA in each cell line. The normal-
ized intensity from HCT116 / cells is held
at 1.
(D) / HCT116 cells (left) and same cells 48
hr following infection with adenovirus ex-
pressing Orc2. Ten micrograms total cell ly-
sate immunoblotted with-Orc2 antibody. “*”
indicates a background band indicating equal
loading in the two lanes.
(E) p367 replication in / HCT116 infected with adenovirus expressing GFP (G, lane 3) or Orc2 (O2, lane 4). Lanes 1 and 2 contain bacterial
p367 mixed with genomic DNA from mock-transfected / HCT116 cells. DNA in all lanes was linearized with BamHI, and in indicated lanes
digested with DpnI.
(F) Rescue of oriP-based plasmid replication in / HCT116 cells by adenovirus expressing full-length Orc2 (from Figure 5E). The normalized
intensity of replicated DNA in / cells is held at 1.
plasmid DNA, GST-geminin inhibits replication of p367 from ORC are likely to play a role in DNA replication
from oriP.(lane 4). GST-gemininDB, which expresses a higher
concentration of the protein (data not shown), inhibits
replication from p367 to a greater extent (lane 5). Quanti- Discussion
tation of the results confirms that geminin suppresses
replication from OriP (Figure 7B). Null mutations of essential genes are difficult to study
in mammalian cells, preventing the genetic evaluationWe attempted to reverse the repressive effect of gemi-
nin by coexpressing Cdt1 (Figure 7C). Because an ex- of the DNA replication machinery of cancer cells. Here,
we solve this problem by creating a hypomorphic muta-cess of Cdt1 (relative to geminin) is required for the
rescue, and because of limits on the maximum amount tion in the human ORC2 gene in a cancer cell line. The
results indicate that Orc2 plays a role in moving cellsof plasmid that can be transfected, the ratio of the gemi-
nin expressing plasmid to p367 (0.83) was lower than from G1 into S, but once in S, the / cells replicate
chromosomal DNA normally. One possibility is that thein Figures 7A and 7B (2.0) accounting for the weaker
inhibition of replication by geminin. Cdt1 rescued inhibi- assembly of pre-RCs is stochastic and the number of
assembled pre-RCs must exceed a certain thresholdtion by geminin (Figure 7C) but did not stimulate oriP
replication when expressed alone (data not shown). before mammalian cells can enter S phase. At low con-
centration of ORC (in / cells), G1 phase is prolonged,Therefore, Cdt1 and other initiation factors downstream
ORC and Latent EBV Replication
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Figure 6. Association of ORC with oriP and EBNA-1
(A) Association of ORC with oriP, detected by ChIP. Cross-linked
chromatin (30g) from 293 cells carrying the plasmid p818 (diagram,
above) was precipitated using antibodies specific to EBNA-1, Orc2, Figure 7. Geminin Inhibits Latent EBV Replication
or with nonimmune serum (N.I.), as indicated (gel image, below). (A) Geminin inhibits replication of EBV-based episome. Southern
Either 1/250 of the recovered DNA (lanes 2, 4, and 6) or 1/1250 blot to detect DpnI-resistant p367 plasmids that have replicated in
(lanes 1, 3, and 5) was tested by PCR for four regions of the plasmid HCT116 / cells following cotransfection of 2 g of p367 with 4
simultaneously. For lanes 7–9, 0.3 ng, 1.5 ng, and 7.6 ng, respec-
g each of plasmids expressing GST (lane 3), GST-geminin (lane
tively, of the input chromatin were tested in parallel. Shown is the 4), and GST-geminin-DB (lane 5). Lanes 1 and 2 are the same as
reverse image of an agarose gel stained with SYBR Gold. The ampli- in Figure 5E.
fied regions of the plasmid are indicated inside the circle of the (B) Inhibition of oriP-based replication by geminin (from Figure 7A).
diagram, and the PCR products, ranging from 182 bp to 435 bp, The normalized intensity of replicated DNA in cells transfected with
are indicated at the right of the gel image. Also indicated for p818 EBG is held at 1.
are the EBNA-1 gene and flanking sequences (black), oriP, its DS (C) Rescue of geminin-induced inhibition by Cdt1. One microgram
and FR components, and flanking sequences (light gray), and the of EBG geminin and 1 or 3 g of CMV-Cdt1 was cotransfected with
hygromycin B-resistance gene (hph, dark gray). 1.2 g p367. Variable amounts of pcDNA3 were added to keep the
(B) Immunoprecipitation of 250g of lysate from DG75 cells carrying total amount of DNA constant for each transfection.
p818 with -Orc2 antibody and preimmune serum. The immuno-
precipitates were immunoblotted with -Orc2 antibody and with
-EBNA1 antibody OT1x. Input lanes contain 12.5 g (for Orc2) and
25 g (for EBNA1) of the cell lysate. Although the / cells suffered a 90% decrease in
the abundance of Orc2 protein and at least a 75% de-
crease in the amount of chromatin-bound ORC, thereas cells need more time to form enough pre-RCs to
enter S. Once enough pre-RCs have been assembled was only a minor effect on cellular replication as as-
sessed by the duration of S phase and the origin activityto allow a successful S phase, DNA replication proceeds
as in wild-type cells. Alternatively, ORC proteins have of known cellular origins. This result suggests that the
amount of Orc2 normally present in cells is in excessbeen postulated to play a role in chromosome structure
and gene silencing (Ehrenhofer-Murray et al., 1995; Foss over what is required for DNA replication. In S. cerevis-
iae, removal of 90% of the known origins of replicationet al., 1993; Pak et al., 1997). The decrease in ORC in
/ cells might increase the expression of inhibitors of from a chromosome still permits replication of the chro-
mosome in the normal duration of S phase (Dershowitzthe G1-S transition, resulting in a prolongation of the
G1 phase. and Newlon, 1993). We show that mammalian chromo-
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somes could replicate normally with less than 25% of that geminin and agents that mimic the action of geminin
the normal complement of chromatin-bound replication could cure human cells of latent EBV infection. We be-
initiator proteins. It should be noted, however, that al- lieve that geminin-based therapeutics would have con-
though we failed to find any deficit in origin firing, this siderable advantages over other antiviral agents that
may be due to the specific origins chosen for analysis. inhibit DNA replication. Geminin would be unique among
We cannot completely rule out the possibility that fewer antiviral agents in its ability to inhibit the initiation of
origins fire in the / cells compared to the WT cells. DNA replication but not elongation. Since episomes con-
In contrast to the minimal effects on chromosomal tain only one origin of replication while chromosomes
DNA replication, we provide clear evidence that cellular contain multiple origins (not all of which are necessary
Orc2 is necessary for replication from oriP of EBV. The for cell survival), it is likely that viral episomes would be
extreme sensitivity of the oriP-dependent plasmids to far more sensitive to geminin-based drugs that specifi-
the ORC2 mutation could be because an episome with cally target initiation. This idea is supported by the fact
one origin of replication is more sensitive to partial inhi- that overexpression of geminin has only a minor effect
bition of replication initiation than a larger chromosome on cell cycle progression of mammalian cells (data not
with multiple origins. EBNA1 and oriP are still essential shown), whereas viral replication is strongly inhibited.
for the replication of the EBV-based episomes in Antiviral agents which target the elongation machinery
HCT116 cells (data not shown). The specific association would not have this large therapeutic index, since elon-
of Orc2 with oriP and with EBNA1 supports the notion gation proteins are likely to be equally essential for cellu-
that ORC binds to the EBV plasmid near its origin of lar and viral replication.
replication, probably through the EBNA1 protein, and The discovery that cellular replication initiator proteins
plays a positive role in replication initiation activity. Addi- are necessary to support EBV replication from oriP could
tional work shows that Orc3 and Orc4 are associated also be an important step toward the treatment and
with oriP in chromatin immunoprecipitation experiments prevention of EBV-associated neoplasias. Malignant
(B.C. and J.Y., unpublished results). Orc2 could be re- cells from nasopharyngeal carcinomas, EBV-positive
cruited to additional sites where EBNA1 binds (like the Burkitt’s lymphoma, and Hodgkin’s disease all carry one
FR in the oriP), but we have no evidence of this yet in or more EBV episomes replicating without integration
the ChIP experiments. This might suggest that the stable into the host genome. Since the viral genes that cause
association of ORC with DNA depends not only on the the malignancy are encoded by the EBV episome, elimi-
interaction with EBNA1 but also on additional interac- nation of the episome by treatment with geminin-based
tions with adjoining DNA or proteins at specific sites on agents may help control the malignancy. Another inter-
the oriP. esting possibility is the use of geminin-based agents as
If a sequence-specific DNA binding factor like EBNA1 prophylactics. Geminin-based preventive therapy can
helps recruit ORC to oriP, recruitment of ORC to cellular be used to eliminate latently infected cells in patients
chromosomal origins of replication might also be depen- before they become immunosuppressed (due to pro-
dent on sequence-specific DNA binding factors. Such gression of AIDS, posttransplant therapy, or therapy of
indirect recruitment of mammalian ORC to chromatin autoimmune disease), to prevent the subsequent devel-
by diverse sequence specific factors might explain why opment of malignancy when immunosuppression does
it has been so difficult to find a single DNA sequence set in. Future experiments will explore these possibilities
that acts as a replicator in mammalian chromosomal as well as examine whether ORC is required for lytic
origins of replication. infections of EBV and other herpesviruses. EBV lacks a
Replication licensing is a mechanism by which cells virally encoded replicative helicase. Therefore, as with
ensure that chromosomal origins fire once and only once replication from oriP, lytic replication from oriLyt might
per cell cycle. EBV chromosomes in latently infected be dependent on the MCM helicase and be susceptible
cells also replicate once and only once per cell cycle,
to geminin. In addition, we will test whether ORC and
but the mechanism for this regulation was unclear. The
other cellular replication initiation factors are required
replication licensing mechanism operates at the level of
for the chronic maintenance in human cells of otherpre-RC formation such that the assembly of pre-RCs is
double-stranded DNA viruses.permitted in G1 phase but actively inhibited during the
S, G2, and M phases of the cell cycle. The implication
of ORC and other components of the pre-RC (Cdt1 by Experimental Procedures
extension from geminin) in replication from oriP can now
Orc2 Targeting Construct and Screening for Recombinantsexplain how viral chromosomes are subjected to the
A promoterless strategy was adapted for targeting the Orc2 genesame replication licensing mechanism that controls cel-
(Waldman et al., 1995). A BAC clone (GenBank accession number
lular chromosomes. AC005037) containing human Orc2 was obtained from Genome Se-
The inhibition of replication from oriP by coexpression quencing Center at Washington University (St. Louis) and used as
of geminin confirms by an independent mechanism that the source for homologous arms. The two PCR amplified fragments,
the EBV-based plasmid utilizes cellular replication initia- one 3.8 kb and the second 1.0 kb, were used to construct the 5
and 3 arms of the targeting vector, respectively. The 3.8 kb subclonetion factors for DNA replication. Rescue of this inhibition
contained the region immediately 5 of the initiation codon locatedby Cdt1 implicates this protein in a replication function in
in exon 3 of the Orc2 coding region. The 1.0 kb subclone containedmammalian cells. Consistent with the fact that geminin
a region beginning 72 bp distal to the initiation codon. Two frag-
inhibits the loading of MCM proteins on Xenopus chro- ments were assembled in pKO plasmid (Stratagene) surrounding a
matin, MCM proteins have also been detected on OriP in promoterless geneticin-resistant gene containing simian virus 40
chromatin immunoprecipitation experiments (B.C. and polyadenylation signals (Neo cassette) (Figure 1A). loxP sites sur-
rounding the Neo cassette were incorporated into the vector. ForJ.Y., unpublished results). These results also suggest
ORC and Latent EBV Replication
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first allele targeting, G418-resistant clones were screened by geno- gemininDB are available on request. For the rescue of oriP expres-
sion in / cells, cells were infected with adenovirus for 1 hr, themic Southern blotting with a hybridization probe located immedi-
ately outside the 3 homologous arm and geneticin-resistant gene medium changed and then transfected with p367 1 hr later. DNA
was harvested at 96 hr to assess plasmid replication. To studycoding region (Figure 1A). A clone carrying a homologous recombi-
nant and no additional random integrants was then infected with the effect of geminin, Cdt1, or Orc2, the appropriate expression
plasmids were cotransfected with p367. Quantitation was done us-recombinant adenovirus expressing Cre recombinase (purchased
from Gene Transfer Vector Core, University of Iowa) to yield G418- ing densitometry or a phosphoimager to normalize the intensity of
the DpnI-resistant fragment (replicated DNA) to that of the largestsensitive clones. One of these heterozygous clones without Neo
(/ Cre) was then used for second round homologous recombina- fragment created by DpnI digestion in the same lane (unreplicated
DNA). These normalized intensities are presented as “relative inten-tion using the same targeting vector. Genomic DNA was prepared
from G418-resistant clones and analyzed by PCR. Homologous re- sities” to facilitate comparison with the first bar in each panel.
combinants identified by PCR were confirmed by Southern blot
(data not shown) and several clones with both alleles of Orc2 dis- Chromatin Immunoprecipitation (ChIP)
rupted were obtained and used for further experiments. Details of 293 cells carrying p818 were grown in Iscove’s modified Dulbecco’s
the constructs and PCR primer sequences are available upon re- Medium containing 275 g/ml hygromycin B (Calbiochem). p818
quest. (Figure 6A) is a 12.6 kb plasmid similar to p201 (Yates et al., 1985)
but contains 4 kb of additional EBV DNA to the right of oriP extending
Western Blot Analysis, Immunoprecipitation, and Chromatin to the BamHI site at 13215. 2  108 cells were trypsinized, washed
Fraction Preparation in PBS, and fixed in PBS containing 1% para-formaldehyde for 20
Orc2 antibody was raised against a fragment of human Orc2 (27–577 min at 37	C. The fixed cells were washed, and chromatin solubilized
amino acids) (Quintana et al., 1997). Conditions for immunoprecipi- in urea as described (Ip et al., 1988). Chromatin was sonicated to
tation and immunoblotting have been described (Dhar and Dutta, an average DNA length of 600 bp. Cross-linked chromatin with a
2000; Thome et al., 2000). Cells were lysed in CSK buffer (100 mM buoyant density of 1.4 gm/ml was purified using a CsCl gradient
NaCl and 2 mM MgCl2), and the chromatin pellet extracted with (Orlando et al., 1997). Thirty micrograms of chromatin DNA was
DNaseI and CSK buffer (200 mM NaCl and 2 mM MgCl2) to prepare adjusted to 50 l in RIPA buffer (1% Triton X-100, 0.1% sodium
the chromatin fraction (Tatsumi et al., 2000). deoxycholate, 0.1% SDS, 150 mM NaCl, 5mM EDTA, 50 mM Tris
HCl [pH 8.0], and 1 mM PMSF) and incubated at 4	C for 4 hr with
1.5 g of -EBNA-1 antibody, EBNA1.OTX1x (Chen et al., 1993), or 1Cell Proliferation and Cell Cycle Analysis
l each of -Orc2 or nonimmune rabbit serum. Antibody complexesCells were counted after trypan blue treatment or by MTT based
were recovered on protein A Sepharose, washed 5 times with RIPAcolorimetric assay (Roche). Cells were synchronized to G1-S by 0.4
buffer (0.75 M NaCl), 2 times in LiCl buffer (0.25 M LiCl, 0.5% TritonmM mimosine (Sigma) for 24 hr. Standard methods were used for
X-100, 1% sodium deoxycholate, 1% SDS, 1 mM EDTA, and 10 mMflow-cytometry analysis and FlowJo software used for estimation
Tris HCl [pH 8.0]), 2 times in TE (10 mM Tris HCl [pH 8.0] and 1 mMof percentage of cells in various phases of the cell cycle.
EDTA), and resuspended in 100 l of TE. Chromatin was de-cross-
linked in 0.5% SDS and proteinase K (1 mg/ml) at 37	C overnightPCR Analysis for Nascent Strand Abundance
followed by 65	C for 8 hr. DNA was extracted with phenol/chloroformDNA replication initiation frequencies at the human c-Myc and
and ethanol precipitated.-globin locus were determined based on short nascent DNA abun-
PCR was performed using 1/250 or 1/1250 of the ChIP DNA in 50dance (Aladjem et al., 1998; Kamath and Leffak, 2001; Malott and
l using 2.5 units Taq polymerase (Roche) for 35 cycles of 1 min atLeffak, 1999; Tao et al., 2000). The 1–2 kb fraction of nascent DNA
95	C, 1 min at 60	C, and 40 s at 72	C. Four primer pairs were usedwas isolated by alkaline gel lysis of cells in logarithmic growth and
to amplify regions of the plasmid simultaneously: 435 bp spanningquantitated by slot blot hybridization. The results shown are based
DS at oriP (EBV 8758–9192), 334 bp located 5 of the EBNA-1 codingon quantitative real time PCR (ABI GeneAmp 5700) (Myc1-3, G1-4)
region (EBV 107656–107989), 248 bp located 3 of the EBNA-1 cod-or competitive PCR (Myc4, G5) to quantitate nascent strand copy
ing region (EBV 109726–109973), and 182 bp near the 5 end of thenumber at sequence-tagged sites in the c-myc locus (GenBank
hph gene (275–456 of GenBank K01193). Primer sequences areAF176208) Myc1 (nt 3896–3964); (GenBank J00120) Myc2 (nt 1829–
available on request. To obtain equal amplification of the four re-1891), Myc3 (nt 4488–4552), Myc4 (nt 5801–6045), and the -globin
gions using control DNA from de-cross-linked chromatin, the primerlocus (GenBank U01317) G1 (nt 32777–32854), G2 (nt 40916–
pairs were used at the following concentrations: DS, 80 nM; 5 of40997), G3 (nt 54401–54475), G4 (nt 61821–61894), G5 (nt 72319–
the EBNA-1 gene, 50 nM; 3 of the EBNA-1 gene, 30 nM; and hph72453). Competitive PCR at Myc1, Myc2, Myc3, G2, and G4 were
gene, 35 nM. The PCR products were separated by electrophoresisused to confirm the results of the Q-PCR. Values are normalized to
in 2% agarose gels (NuSieve 3:1, Biowhittaker), detected by stainingthe abundance at Myc3. PCR primer sequences are available on
with SYBR Green (Molecular Probes), and digitally photographed.request.
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